Do analysts prefer RMTI or EVTV?

Rockwell Medical presently has a consensus target price of $20.00, suggesting a potential upside of 144.80%. Given Rockwell Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Rockwell Medical is more favorable than Envirotech Vehicles. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Envirotech Vehicles 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate RVP or RMTI?

Rockwell Medical has a consensus price target of $20.00, indicating a potential upside of 144.80%. Given Rockwell Medical's stronger consensus rating and higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer RMTI or LUCY?

Rockwell Medical currently has a consensus target price of $20.00, indicating a potential upside of 144.80%. Given Rockwell Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Rockwell Medical is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to RMTI or LUCY?

In the previous week, Innovative Eyewear had 15 more articles in the media than Rockwell Medical. MarketBeat recorded 17 mentions for Innovative Eyewear and 2 mentions for Rockwell Medical. Rockwell Medical's average media sentiment score of 1.27 beat Innovative Eyewear's score of -0.42 indicating that Rockwell Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rockwell Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Innovative Eyewear 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to RMTI or BMRA?

In the previous week, Biomerica had 6 more articles in the media than Rockwell Medical. MarketBeat recorded 8 mentions for Biomerica and 2 mentions for Rockwell Medical. Rockwell Medical's average media sentiment score of 1.27 beat Biomerica's score of 1.22 indicating that Rockwell Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rockwell Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Biomerica 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Rockwell Medical (RMTI) Competitors

$8.17 0.00 (0.00%)

Closing price 08/28/2026 04:00 PM Eastern

Extended Trading

$8.13 -0.04 (-0.49%)

As of 04:06 AM Eastern

Compare

RMTI vs. NEPH, EVTV, RVP, LUCY, and BMRA

Should you buy Rockwell Medical stock or one of its competitors? Rockwell Medical's main competitors and comparable companies include Nephros (NEPH), Envirotech Vehicles (EVTV), Retractable Technologies (RVP), Innovative Eyewear (LUCY), and Biomerica (BMRA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Rockwell Medical compare to Nephros?

Rockwell Medical (NASDAQ:RMTI) and Nephros (NASDAQ:NEPH) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 41.1% of Nephros shares are owned by institutional investors. 4.6% of Rockwell Medical shares are owned by company insiders. Comparatively, 6.7% of Nephros shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Rockwell Medical had 1 more articles in the media than Nephros. MarketBeat recorded 2 mentions for Rockwell Medical and 1 mentions for Nephros. Nephros' average media sentiment score of 1.89 beat Rockwell Medical's score of 1.27 indicating that Nephros is being referred to more favorably in the news media.

Company	Overall Sentiment
Rockwell Medical	Positive
Nephros	Very Positive

Rockwell Medical has a beta of 1.6, meaning that its share price is 60% more volatile than the broader market. Comparatively, Nephros has a beta of 1.51, meaning that its share price is 51% more volatile than the broader market.

Nephros has lower revenue, but higher earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Nephros, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.48	-$5.31M	-$1.34	N/A
Nephros	$18.79M	2.63	$1.19M	$0.16	28.44

Rockwell Medical presently has a consensus price target of $20.00, suggesting a potential upside of 144.80%. Nephros has a consensus price target of $4.00, suggesting a potential downside of 12.09%. Given Rockwell Medical's higher possible upside, equities analysts plainly believe Rockwell Medical is more favorable than Nephros.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nephros	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25

Nephros has a net margin of 8.38% compared to Rockwell Medical's net margin of -7.33%. Nephros' return on equity of 10.60% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.33%	-14.03%	-8.90%
Nephros	8.38%	10.60%	8.05%

Summary

Nephros beats Rockwell Medical on 11 of the 15 factors compared between the two stocks.

How does Rockwell Medical compare to Envirotech Vehicles?

Rockwell Medical (NASDAQ:RMTI) and Envirotech Vehicles (NASDAQ:EVTV) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

Rockwell Medical has higher revenue and earnings than Envirotech Vehicles. Rockwell Medical is trading at a lower price-to-earnings ratio than Envirotech Vehicles, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.48	-$5.31M	-$1.34	N/A
Envirotech Vehicles	$5.94M	4.24	-$39.13M	-$6.45	N/A

Rockwell Medical has a net margin of -7.33% compared to Envirotech Vehicles' net margin of -382.71%. Rockwell Medical's return on equity of -14.03% beat Envirotech Vehicles' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.33%	-14.03%	-8.90%
Envirotech Vehicles	-382.71%	-1,284.22%	-181.53%

In the previous week, Rockwell Medical had 2 more articles in the media than Envirotech Vehicles. MarketBeat recorded 2 mentions for Rockwell Medical and 0 mentions for Envirotech Vehicles. Rockwell Medical's average media sentiment score of 1.27 beat Envirotech Vehicles' score of 0.00 indicating that Rockwell Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Rockwell Medical	Positive
Envirotech Vehicles	Neutral

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 5.7% of Envirotech Vehicles shares are held by institutional investors. 4.6% of Rockwell Medical shares are held by insiders. Comparatively, 17.8% of Envirotech Vehicles shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Rockwell Medical has a beta of 1.6, suggesting that its share price is 60% more volatile than the broader market. Comparatively, Envirotech Vehicles has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market.

Rockwell Medical presently has a consensus target price of $20.00, suggesting a potential upside of 144.80%. Given Rockwell Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Rockwell Medical is more favorable than Envirotech Vehicles.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envirotech Vehicles	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Rockwell Medical beats Envirotech Vehicles on 13 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and Rockwell Medical (NASDAQ:RMTI) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends.

Retractable Technologies has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market.

Rockwell Medical has a consensus price target of $20.00, indicating a potential upside of 144.80%. Given Rockwell Medical's stronger consensus rating and higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Rockwell Medical had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for Rockwell Medical and 0 mentions for Retractable Technologies. Rockwell Medical's average media sentiment score of 1.27 beat Retractable Technologies' score of 0.00 indicating that Rockwell Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Neutral
Rockwell Medical	Positive

Rockwell Medical has higher revenue and earnings than Retractable Technologies. Rockwell Medical is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$33.90M	0.64	-$7.01M	-$0.12	N/A
Rockwell Medical	$69.26M	0.48	-$5.31M	-$1.34	N/A

Rockwell Medical has a net margin of -7.33% compared to Retractable Technologies' net margin of -41.11%. Rockwell Medical's return on equity of -14.03% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Rockwell Medical	-7.33%	-14.03%	-8.90%

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by insiders. Comparatively, 4.6% of Rockwell Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Rockwell Medical beats Retractable Technologies on 12 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Innovative Eyewear?

Rockwell Medical (NASDAQ:RMTI) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

Rockwell Medical has a net margin of -7.33% compared to Innovative Eyewear's net margin of -225.26%. Rockwell Medical's return on equity of -14.03% beat Innovative Eyewear's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.33%	-14.03%	-8.90%
Innovative Eyewear	-225.26%	-88.90%	-80.34%

Rockwell Medical has higher revenue and earnings than Innovative Eyewear. Rockwell Medical is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.48	-$5.31M	-$1.34	N/A
Innovative Eyewear	$3.41M	2.40	-$7.59M	-$1.29	N/A

Rockwell Medical has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.72, indicating that its share price is 172% more volatile than the broader market.

In the previous week, Innovative Eyewear had 15 more articles in the media than Rockwell Medical. MarketBeat recorded 17 mentions for Innovative Eyewear and 2 mentions for Rockwell Medical. Rockwell Medical's average media sentiment score of 1.27 beat Innovative Eyewear's score of -0.42 indicating that Rockwell Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rockwell Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Innovative Eyewear	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 4.6% of Rockwell Medical shares are owned by insiders. Comparatively, 1.7% of Innovative Eyewear shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Rockwell Medical currently has a consensus target price of $20.00, indicating a potential upside of 144.80%. Given Rockwell Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Rockwell Medical is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Rockwell Medical beats Innovative Eyewear on 11 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Biomerica?

Rockwell Medical (NASDAQ:RMTI) and Biomerica (NASDAQ:BMRA) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

Rockwell Medical has a beta of 1.6, indicating that its stock price is 60% more volatile than the broader market. Comparatively, Biomerica has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market.

Rockwell Medical has a net margin of -7.33% compared to Biomerica's net margin of -96.49%. Rockwell Medical's return on equity of -14.03% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.33%	-14.03%	-8.90%
Biomerica	-96.49%	-98.14%	-70.42%

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 22.3% of Biomerica shares are owned by institutional investors. 4.6% of Rockwell Medical shares are owned by company insiders. Comparatively, 18.0% of Biomerica shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Biomerica had 6 more articles in the media than Rockwell Medical. MarketBeat recorded 8 mentions for Biomerica and 2 mentions for Rockwell Medical. Rockwell Medical's average media sentiment score of 1.27 beat Biomerica's score of 1.22 indicating that Rockwell Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rockwell Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Biomerica	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Biomerica has lower revenue, but higher earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Biomerica, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.48	-$5.31M	-$1.34	N/A
Biomerica	$5.31M	1.25	-$4.97M	-$0.89	N/A

Rockwell Medical presently has a consensus price target of $20.00, indicating a potential upside of 144.80%. Biomerica has a consensus price target of $9.00, indicating a potential upside of 320.56%. Given Biomerica's higher probable upside, analysts plainly believe Biomerica is more favorable than Rockwell Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Rockwell Medical beats Biomerica on 9 of the 16 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RMTI vs. The Competition

Export

Metric	Rockwell Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$32.93M	$5.78B	$7.18B	$12.89B
Dividend Yield	N/A	1.75%	2.54%	11.27%
P/E Ratio	-6.10	25.92	273.17	25.45
Price / Sales	0.48	78.92	638.21	103.75
Price / Cash	N/A	33.69	28.74	36.03
Price / Book	0.87	6.18	11.08	6.36
Net Income	-$5.31M	$149.94M	$3.48B	$349.79M
7 Day Performance	3.42%	-0.22%	0.38%	-0.40%
1 Month Performance	13.63%	6.39%	7.89%	4.24%
1 Year Performance	-52.22%	6.29%	24.71%	15.13%

Rockwell Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RMTI Rockwell Medical	3.4987 of 5 stars	$8.17 flat	$20.00 +144.8%	-52.2%	$32.93M	$69.26M	N/A	300	Positive News Gap Down
NEPH Nephros	2.9039 of 5 stars	$4.31 -2.3%	$4.00 -7.2%	+22.0%	$46.81M	$18.79M	26.94	30
EVTV Envirotech Vehicles	N/A	$1.95 +0.3%	N/A	-13.9%	$25.16M	$5.94M	N/A	10
RVP Retractable Technologies	N/A	$0.72 -2.1%	N/A	-12.5%	$21.41M	$33.90M	N/A	240
LUCY Innovative Eyewear	0.9924 of 5 stars	$1.09 -3.1%	N/A	-50.8%	$9.34M	$3.41M	N/A	9	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RMTI) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rockwell Medical (RMTI) Competitors

RMTI vs. NEPH, EVTV, RVP, LUCY, and BMRA

How does Rockwell Medical compare to Nephros?

Summary

How does Rockwell Medical compare to Envirotech Vehicles?

Summary

How does Rockwell Medical compare to Retractable Technologies?

Summary

How does Rockwell Medical compare to Innovative Eyewear?

Summary

How does Rockwell Medical compare to Biomerica?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RMTI vs. The Competition

Rockwell Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rockwell Medical (RMTI) Competitors

RMTI vs. NEPH, EVTV, RVP, LUCY, and BMRA

How does Rockwell Medical compare to Nephros?

Do institutionals and insiders have more ownership in RMTI or NEPH?

Does the media refer more to RMTI or NEPH?

Which has more risk and volatility, RMTI or NEPH?

Which has higher valuation & earnings, RMTI or NEPH?

Do analysts rate RMTI or NEPH?

Is RMTI or NEPH more profitable?

Summary

How does Rockwell Medical compare to Envirotech Vehicles?

Which has stronger earnings & valuation, RMTI or EVTV?

Is RMTI or EVTV more profitable?

Does the media prefer RMTI or EVTV?

Do insiders and institutionals have more ownership in RMTI or EVTV?

Which has more volatility & risk, RMTI or EVTV?

Do analysts prefer RMTI or EVTV?

Summary

How does Rockwell Medical compare to Retractable Technologies?

Which has more volatility & risk, RVP or RMTI?

Do analysts rate RVP or RMTI?

Does the media favor RVP or RMTI?

Which has higher earnings and valuation, RVP or RMTI?

Is RVP or RMTI more profitable?

Do insiders & institutionals believe in RVP or RMTI?

Summary

How does Rockwell Medical compare to Innovative Eyewear?

Is RMTI or LUCY more profitable?

Which has stronger earnings and valuation, RMTI or LUCY?

Which has more risk & volatility, RMTI or LUCY?

Does the media refer more to RMTI or LUCY?

Do insiders and institutionals have more ownership in RMTI or LUCY?

Do analysts prefer RMTI or LUCY?

Summary

How does Rockwell Medical compare to Biomerica?

Which has more volatility & risk, RMTI or BMRA?

Is RMTI or BMRA more profitable?

Do institutionals & insiders have more ownership in RMTI or BMRA?

Does the media refer more to RMTI or BMRA?

Which has better valuation and earnings, RMTI or BMRA?

Do analysts prefer RMTI or BMRA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RMTI vs. The Competition

Rockwell Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools